This website uses cookies to ensure you get the best experience on our website.
Privacy Policy
I Agree
UroToday
Contact
Login
Sign Up Free
Transformative Evidence
mCRPC
PEACE-3 Trial
PROfound Trial
The RALU Study: Treatment Considerations in the First Line Setting of mCRPC
VISION Trial
mHSPC
ARANOTE Trial
ARASENS Trial
nmCRPC
ARAMIS Trial
nmCSPC
EMBARK Trial
PSMA PET Imaging
COBRA Trial
CONDOR Trial
OSPREY Trial
Bladder Cancer
ANKTIVA
Bladder Cancer Detection
CORE-001 Study
EV-302
Centers of Excellence
Urologic Oncology
Left Group
Health Policy
Health Policy
Ruchika Talwar, MD
Bladder Cancer
Bladder Cancer
Ashish Kamat, MD
Advanced Bladder Cancer
Shilpa Gupta, MD
Trimodality Therapy
Leslie Ballas, MD
Kidney Cancer
Advanced Kidney Cancer
Pedro Barata, MD, MSc
Endourology
Endourology
Jaime Landman, MD
Prostate Cancer
Localized Prostate Cancer
Matthew R. Cooperberg, MD, MPH
Decipher Genomic Classifier
Imaging Center
Phillip Koo, MD
mHSPC
Neeraj Agarwal, FASCO, MD
nmCRPC
Zachary Klaassen, MD, MSc
mCRPC Treatment
A. Oliver Sartor, MD
mCRPC with Bone Metastasis
Alicia Morgans, MD, MPH
PSMA-Targeted Therapy
Advanced Prostate Cancer
Zachary Klaassen, MD, MSc
Disparities: Social Determinants of Health
Disparities: Social Determinants of Health
Samuel L. Washington III, MD, MAS
Translational Prostate Cancer
Translational Science in Prostate Cancer
Andrea Miyahira, Ph.D
Women in Science
Andrea Miyahira, Ph.D
Upper Tract Urothelial Carcinoma
Upper Tract Urothelial Carcinoma
Sam S. Chang, MD, MBA
TESTICULAR, PENILE & RARE GU MALIGNANCIES
Testicular Cancer
Pelvic Health & Reconstruction
Bladder Health
Diane K. Newman, DNP, ANP-BC, FAAN
Pelvic Health
Diane K. Newman, DNP, ANP-BC, FAAN
Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction (SUFU)
Stephen R. Kraus, MD
Urologic Catheters (Includes CAUTI)
Diane K. Newman, DNP, ANP-BC, FAAN
Videos
Exclusives
Conferences
Exclusive Collaborations
Independent Medical Education
Covid-19
The Prostate Cancer Foundation
Health Policy in Urological Diseases
Disparities: Social Determinants of Health
Practice Guidelines Reviews
Urologic Oncology
Prostate Cancer
Bladder Cancer
Kidney Cancer
Upper Tract Urothelial Tumors
Testicular Cancer
Endourology
Pelvic Health & Reconstruction
Pelvic Health & Reconstruction
Actionable Clinical Data
Kidney Cancer
ZIRCON
Trials in Progress
Trials in Progress
Bladder Cancer
BOND-003 Cohort P
CORE-008
IMMORTAL
PIVOT-006
Kidney Cancer
RadiCal
SAMURAI
Middle Side
Prostate Cancer
ARAMON
ARASEC
ARASTEP
CLARIFY
ECLIPSE
ESCAPE
FORT
Right Side
Prostate Cancer
METANOVA
NRG-GU 0101
PROMISE
RTIRE
SECuRE
SHORTER
Clinical Trials
From the Editor
Search Clinical Trials
Articles
Urology (benign and malignant)
Urologic Oncology
Men's Health
Endourology & Stones
Pediatric Urology
COVID-19 and Genitourinary Cancers
Pelvic Health
Pelvic Health & Reconstruction
Conference Coverage
Recent Conferences
ASCO GU 2025
SUO 2024
SCS AUA 2024
ASTRO 2024
IBCN 2024
ESMO 2024
All Conferences
View All
Quick Takes
ESMO 2024
PCF
UroToday Home
Recent Abstracts
Urologic Oncology
Prostate Cancer
Recent Abstracts
Reversal of PSA progression on abiraterone acetate through the administration with food in men with metastatic castration-resistant prostate cancer - Abstract
May 9, 2015
Accuracy of magnetic resonance imaging/ultrasound fusion targeted biopsies to diagnose clinical significant prostate cancer in enlarged compared to smaller prostate - Abstract
May 9, 2015
Importance of prostate volume in the stratification of patients with intermediate-risk prostate cancer - Abstract
May 9, 2015
Oncological outcome after radical prostatectomy: Marital status does not make a difference - Abstract
May 9, 2015
Can anorectal manometry findings predict subsequent late gastrointestinal radiation toxicity in prostate cancer patients? - Abstract
May 9, 2015
Quality of life after brachytherapy or robot-assisted radical prostatectomy for localized prostate cancer - Abstract
May 9, 2015
A population-based study of men with low-volume low-risk prostate cancer: Does African-American race predict for more aggressive disease? - Abstract
May 9, 2015
Doctors' approaches to PSA testing and overdiagnosis in primary healthcare: A qualitative study - Abstract
May 9, 2015
Somatostatin imaging of neuroendocrine-differentiated prostate cancer - Abstract
May 9, 2015
11C-choline PET/CT identifies osteoblastic and osteolytic lesions in patients with metastatic prostate cancer - Abstract
May 9, 2015
Update of the results of the Spanish branch of the European randomized study on screening for prostate cancer (ERSPC) - Abstract
May 7, 2015
An adaptive MR-CT registration method for MRI-guided prostate cancer radiotherapy - Abstract
May 7, 2015
Future-proofing Gleason grading: What to call Gleason 6 prostate cancer? - Abstract
May 7, 2015
Organ-confined prostate cancer: Are we moving towards more or less radical surgical intervention? - Abstract
May 7, 2015
Lymph node staging in prostate cancer - Abstract
May 7, 2015
Targeted MRI/TRUS fusion-guided biopsy in men with previous prostate biopsies using a novel registration software and multiparametric MRI PI-RADS scores: First results - Abstract
May 7, 2015
Management of non metastatic castration resistant prostate cancer - Abstract
May 7, 2015
Functional outcomes of partial prostate ablation and focal therapy: Are we managing expectations of a bar set too high? - Abstract
May 7, 2015
When should we perform a bone scintigraphy in patients with new diagnosis of asymptomatic prostate cancer in order to detect bone metastasis? - Abstract
May 7, 2015
Radioimmunotherapy of metastatic prostate cancer with 177Lu-DOTA-huJ591 anti prostate specific membrane antigen specific monoclonal antibody - Abstract
May 7, 2015
Page 927 of 1457
Start
Prev
922
923
924
925
926
927
928
929
930
931
Next
End
×
Login
Login to update email address, newsletter preferences and use bookmarks.
Email
Password
Login
Forgot Password?
Sign Up Free